5:48 PM
 | 
Oct 22, 2013
 |  BC Extra  |  Financial News

Amgen beats Street, ups guidance

Amgen Inc. (NASDAQ:AMGN) reported 3Q13 earnings that beat the Street and again increased its full-year EPS and revenue guidance. Adjusted diluted EPS in the quarter was $1.94, above the Street's $1.77 estimate and up from $1.67 in 3Q12. Revenues in the quarter were $4.7 billion, beating...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >